Cresco Labs (CRLBF) Profit After Tax (2019 - 2026)
Cresco Labs' (CRLBF) quarterly Profit After Tax came in at -$17.0 million in Q1 2026, down 11.68% YoY from -$19.3 million in Q1 2025, and up 80.87% on a QoQ basis from -$88.9 million in Q4 2025.
Cresco Labs (CRLBF) Profit After Tax (2019 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 8 years of Profit After Tax data on file, last reported at -$17.0 million in Q1 2026.
- Quarterly Profit After Tax fell 11.68% year-over-year to -$17.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$141.8 million (down 92.52% YoY) and the FY2025 annual result came in at -$134.8 million, down 81.1% from the prior year.
- Profit After Tax climbed to -$17.0 million in Q1 2026, from -$88.9 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $8.3 million in Q2 2022 to a low of -$180.6 million in Q4 2022.
- A 5-year average of -$35.1 million and a median of -$17.0 million in 2026 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax soared 212.7% — and 2025, when it tumbled 20361.73%.
- Tracing CRLBF's Profit After Tax over 5 years: stood at -$180.6 million in 2022, then surged by 102.7% to $4.9 million in 2023, then slumped by 90.98% to $439000.0 in 2024, then plunged by 20361.73% to -$88.9 million in 2025, then jumped by 80.87% to -$17.0 million in 2026.
- The last three Profit After Tax figures came in at -$17.0 million (Q1 2026), -$88.9 million (Q4 2025), and -$22.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Cresco Labs | 291.27 Mn | 227.16 Mn | 86.95 Mn | 15.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.01 Mn |
| Dec 31, 2025 | -88.95 Mn |
| Sep 30, 2025 | -21.97 Mn |
| Jun 30, 2025 | -13.89 Mn |
| Mar 31, 2025 | -15.23 Mn |
| Dec 31, 2024 | 439,000.00 |
| Sep 30, 2024 | -7.69 Mn |
| Jun 30, 2024 | -51.18 Mn |
| Mar 31, 2024 | -2.06 Mn |
| Dec 31, 2023 | 4.87 Mn |
| Sep 30, 2023 | -113.45 Mn |
| Jun 30, 2023 | -43.46 Mn |
| Mar 31, 2023 | -27.81 Mn |
| Dec 31, 2022 | -180.62 Mn |
| Sep 30, 2022 | -3.25 Mn |
| Jun 30, 2022 | 8.30 Mn |
| Mar 31, 2022 | -23.68 Mn |
| Dec 31, 2021 | 11.91 Mn |
| Sep 30, 2021 | -263.45 Mn |
| Jun 30, 2021 | 2.65 Mn |